Zoll gains FDA OK for public use defibrillator:
This article was originally published in Clinica
Executive Summary
Zoll Medical has gained FDA 510(k) approval to market its automated external defibrillator in the US for the emergency treatment of sudden cardiac arrest. The battery-powered Zoll AED Plus device, which features simple, step by step illustrations and audio coaching, is designed to be easy to use for the lay person to assist heart attack victims. It is the first AED to use a single electrode pad that is easy to position on the victim's body, said the Burlington, Massachusetts firm.